Astarta agricultural holding in July 2019 started accepting grain at Semenivsky elevator (Poltava region) with a capacity of 120,000 tonnes and investments of $19.2 million, the press service of the holding has said. According to the report, this elevator is the largest one in Astarta’s structure. It is designed to accept grain from the agricultural holding’s farms and from partners.
The construction of the elevator lasted nine months, it can ship over 54 wagons of grain per day. According to the company, Astarta has seven grain elevators in Poltava, Vinnytsia and Khmelnytsky regions with a total capacity of 550,000 tonnes of grain. As reported, in March 2019 Astarta bought an elevator in Khmelnytsky region for EUR4.6 million.
Astarta after three years of profitable work in 2018 received a net loss of EUR21.11 million. Its revenue decreased by 18.8%, to EUR372.22 million, EBITDA by 2.1 times, to EUR56.87 million.
Changes in currency exchange, uah/eur, 02.05.19.-27.06.19
The National Bank of Ukraine (NBU) in the period from June 24 to June 27 bought $44 million in the interbank foreign exchange market, which is 8.6% more than a week earlier ($40.5 million).
According to the website of the central bank, $20 million was acquired at the best purchase and sale price (using the matching instrument), $24 million at a single rate (using the matching instrument).
In June, the National Bank bought $322.3 million compared with $203.6 million in May and $299.9 million in April.
In general, since the beginning of this year, the NBU bought $1.639 billion in the interbank market and sold $231.43 million.
National bank of ukraine’s official rates as of 02/07/19
Source: National Bank of Ukraine
The Grand Chamber of the Supreme Court of Ukraine has sent the dispute over the Corvalolum well-known brand to the court of lowest instance for repeated hearing and partially satisfied cassation claims of the Economic Development and Trade Ministry of Ukraine and PJSC Farmak, annulling the ruling of the appeal court and the ruling of the court of lower instance.
Earlier, the Kyiv business court of appeals under the counterclaim of PrJSC Darnitsa Pharmaceutical Firm revoked the decision of the Appeals Chamber of the Ministry of Economic Development and Trade recognizing the designation Corvalolum as well-known.
“PJSC Farmak stands for civilized competition and for many years it has been defending its rights to the Corvalolum well-known brand. We defend our right only to the brand designation,” Farmak Legal Director Dmytro Taranchuk said.
He said that “the medicine itself and its components are not protected by a patent, and it is not protected in Ukraine from the point of view of intellectual property.”
“A similar medicine can be produced by any manufacturer who will prove its quality and effectiveness and undergo all the required licensing procedures. But under a different name, under its own brand,” the lawyer said.